1. CO0001 MAVRILIMUMAB IMPROVES OUTCOMES IN SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPER-INFLAMMATION. (13th June 2020) Authors: De Luca, G.; Cavalli, G.; Campochiaro, C.; Della Torre, E.; Angelillo, P.; Tomelleri, A.; Boffini, N.; Tentori, S.; Mette, F.; Rovere-Querini, P.; Ruggeri, A.; D'aliberti, T.; Scarpelllini, P.; Landoni, G.; De Cobelli, F.; Paolini, J. F.; Zangrillo, A.; Tresoldi, M.; Trapnell, B. C.; Ciceri, F. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LONG‐TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT). (12th June 2019) Authors: Ferreri, A.J.; Sassone, M.C.; Angelillo, P.; Zaja, F.; Re, A.; Spina, M.; Di Rocco, A.; Fabbri, A.; Stelitano, C.; Frezzato, M.; Rusconi, C.; Zambello, R.; Arcari, A.; Bertoldero, G.; De Lorenzo, D.; Volpetti, S.; Calimeri, T.; Perrone, S.; Cecchetti, C.; Ciceri, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗